This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by UC Care, Ltd..
Recruitment status was:  Not yet recruiting
Information provided by (Responsible Party):
UC Care, Ltd. Identifier:
First received: September 12, 2012
Last updated: September 20, 2012
Last verified: September 2012

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of:

  1. Biopsy core length obtained (i.e. collecting all tissue fragments)
  2. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)
  3. Pathologist interpretability
  4. Processing time
  5. Prostate cancer detection.

Condition Intervention
Prostate Cancer Device: NaviGo Bx™ Procedure: biopsy sponge pad

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample

Resource links provided by NLM:

Further study details as provided by UC Care, Ltd.:

Primary Outcome Measures:
  • percent of tissue loss [ Time Frame: 1 year ]
    percent of biopsy tissue loss during pathologic processing. comparing the core length as recorded on the biopsy needle notch and on the histology slide

Secondary Outcome Measures:
  • prostate cancer detection rate [ Time Frame: 1 year ]
  • processing time [ Time Frame: 1 year ]

Estimated Enrollment: 100
Study Start Date: October 2012
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Standard method
Standard method- shaking the biopsy needle into a formalin container.
Active Comparator: Download onto a biopsy sponge pad
Samples will be downloaded by moving the needle notch on a biopsy sponge pad.
Procedure: biopsy sponge pad
the biopsy core is downloaded onto a biopsy sponge pad which is than entered into a biopsy cassette.
Experimental: Dowloading the biopsy cores using NavigoBx system
Downloading the biopsy cores using NavigoBx™ system. The NaviGoBx™ device is intended for the retention of a biopsy specimen and for preservation of the specimen's in-needle location and orientation.
Device: NaviGo Bx™
The NaviGoBx™ system is a device and method that enables an accurate reporting of the exact longitudinal location and direction of the biopsy specimen along the needle notch as well as the accurate length of the specimen. Acquiring this information during the biopsy extraction session provides an accurate designation of the location of any later region of interest within the specimen itself to the longitudinal position along the needle mandrel.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 years or older
  • Planned for radical or open prostatectomy operation or Planned for TRUS prostate biopsy procedure.
  • Signed informed consent.

Exclusion Criteria:

  • Patient's unwilling to participate.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01692405

Haemek madical center Not yet recruiting
Afula, Israel, 18101
Contact: Michael Cohen, Dr.    04-6494306   
Principal Investigator: Michael Cohen, MD         
Sponsors and Collaborators
UC Care, Ltd.
  More Information

Additional Information:
Responsible Party: UC Care, Ltd. Identifier: NCT01692405     History of Changes
Other Study ID Numbers: 0086-12-EMC
Study First Received: September 12, 2012
Last Updated: September 20, 2012 processed this record on August 21, 2017